"Thanks. Is it odd in your mind that it was ineffective for stroke?"
And I forgot to mention that there were no strokes reported in the post-hoc analysis of the Phase 2 ASSURE/SUSTAIN 5-point MACE. Therefore, there is no precedent in the Phase 2s that apabetalone lowered risk of stroke.
https://www.sciencedirect.com/science/article/pii/S0021915016300351